Back to Menu
Chondrosarcoma is a malignant bone tumor of cartilaginous origin, characterized by the production of a cartilaginous matrix. It is the second most common primary malignant bone tumor after osteosarcoma and most frequently occurs in middle-aged and older adults, particularly in the pelvis, proximal femur, and ribs.
1. Conventional chondrosarcoma
The most common subtype (>85%) and graded as I–III according to histologic malignancy.
2. Mesenchymal chondrosarcoma
High-grade malignancy composed of small round cells with islands of cartilage.
3. Dedifferentiated chondrosarcoma
Contains both a low-grade chondrosarcoma component and a high-grade sarcomatous component.
4. Clear cell chondrosarcoma
Relatively low grade, slow growing, and often arises in the proximal femur.
5. Myxoid chondrosarcoma
Rare, characterized by abundant myxoid stroma.
6. Periosteal chondrosarcoma
Arises on the bone surface and is associated with a relatively favorable prognosis.
7. Secondary chondrosarcoma
Develops from malignant transformation of benign cartilaginous lesions (e.g., osteochondroma).
1. Genetic factors
EXT gene mutations associated with hereditary multiple exostoses increase the risk of secondary chondrosarcoma.
2. Malignant transformation of benign disorders
Hereditary multiple exostoses and enchondromatosis can transform into chondrosarcoma.
3. Radiation exposure
Prior radiotherapy is a well-established risk factor, with a latency period of decades.
4. Age
More common in middle-aged and older adults, possibly related to cumulative genomic alterations.
5. Chemical exposure
Certain chemical exposures may increase risk, although mechanisms require further study.
6. Trauma
A causal relationship between trauma and chondrosarcoma has not been scientifically established.
1. Regular monitoring of benign lesions
Patients with hereditary multiple exostoses and other premalignant conditions should undergo periodic imaging to detect malignant transformation.
2. Avoidance of risk factors
Minimize unnecessary radiation exposure; high-risk individuals should receive periodic skeletal surveillance.
3. Healthy lifestyle
Maintain a balanced diet with adequate calcium and vitamin D, engage in appropriate exercise to support skeletal health, and avoid smoking and excessive alcohol use.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that chondrosarcoma can cause severe pain, fractures, and functional impairment, and high-grade subtypes are life-threatening. Early diagnosis and wide surgical resection are key to cure. Radiotherapy and targeted therapies may offer options for patients who are not candidates for surgery. Regular follow-up and MDT-based individualized management are essential for recurrence prevention.
Chondrosarcoma is a malignant bone tumor of cartilaginous origin, characterized by the production of a cartilaginous matrix. It is the second most common primary malignant bone tumor after osteosarcoma and most frequently occurs in middle-aged and older adults, particularly in the pelvis, proximal femur, and ribs.
1. Conventional chondrosarcoma
The most common subtype (>85%) and graded as I–III according to histologic malignancy.
2. Mesenchymal chondrosarcoma
High-grade malignancy composed of small round cells with islands of cartilage.
3. Dedifferentiated chondrosarcoma
Contains both a low-grade chondrosarcoma component and a high-grade sarcomatous component.
4. Clear cell chondrosarcoma
Relatively low grade, slow growing, and often arises in the proximal femur.
5. Myxoid chondrosarcoma
Rare, characterized by abundant myxoid stroma.
6. Periosteal chondrosarcoma
Arises on the bone surface and is associated with a relatively favorable prognosis.
7. Secondary chondrosarcoma
Develops from malignant transformation of benign cartilaginous lesions (e.g., osteochondroma).
1. Genetic factors
EXT gene mutations associated with hereditary multiple exostoses increase the risk of secondary chondrosarcoma.
2. Malignant transformation of benign disorders
Hereditary multiple exostoses and enchondromatosis can transform into chondrosarcoma.
3. Radiation exposure
Prior radiotherapy is a well-established risk factor, with a latency period of decades.
4. Age
More common in middle-aged and older adults, possibly related to cumulative genomic alterations.
5. Chemical exposure
Certain chemical exposures may increase risk, although mechanisms require further study.
6. Trauma
A causal relationship between trauma and chondrosarcoma has not been scientifically established.
1. Regular monitoring of benign lesions
Patients with hereditary multiple exostoses and other premalignant conditions should undergo periodic imaging to detect malignant transformation.
2. Avoidance of risk factors
Minimize unnecessary radiation exposure; high-risk individuals should receive periodic skeletal surveillance.
3. Healthy lifestyle
Maintain a balanced diet with adequate calcium and vitamin D, engage in appropriate exercise to support skeletal health, and avoid smoking and excessive alcohol use.
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that chondrosarcoma can cause severe pain, fractures, and functional impairment, and high-grade subtypes are life-threatening. Early diagnosis and wide surgical resection are key to cure. Radiotherapy and targeted therapies may offer options for patients who are not candidates for surgery. Regular follow-up and MDT-based individualized management are essential for recurrence prevention.